Robert C. Andrade
Chief Financial OfficerMr. Robert C. Andrade has been the Chief Financial Officer of Fennec Pharmaceuticals Inc. since re-joining in November 2015. Mr. Andrade joined the Fennec Pharmaceuticals Inc. in November 2015. Mr. Andrade served as Chief Financial Officer of Fennec Pharmaceuticals Inc. from September 2009 to August 14, 2013 and served as its Vice President since July 2009. Mr. Andrade served as the Principal Accounting Officer at Fennec Pharmaceuticals Inc. He is a General Partner at DCML, a private investment partnership. He Co-Founded and serves as Manager of DCML LLC. He was senior analyst at Magnetar Capital from 2013 to 2014. He served as a Portfolio Manager and Securities Analyst at Millennium Partners L.P. from 2006 to 2007. Mr. Andrade was a Securities Analyst for the Event Driven Fund at Caxton Associates LLC from 2003 to 2005. He served as a Private Equity Associate at Trimaran Capital Partners from 2000 to 2003 and as an Investment Banking Analyst at The Bear Stearns Companies LLC from 1997 to 1999. Mr. Andrade worked in The Leveraged Finance Group of CIBC World Markets. Before to CIBC, he worked in the telecommunications, media and technology group at J.P. Morgan. He served as a Director of Fennec Pharmaceuticals Inc. from July 2009 to August 14, 2013. Mr. Andrade received his B.A. degree and M.A. in Economics from the University of Southern California.
Positions
- Company NameFennec Pharmaceuticals Inc.Stock CodeFENCPositionChief Financial OfficerColleagues
- JSJeffrey S. HackmanCEO & Director
- KIKhalid IslamIndependent Chairman of the Board
- PSPierre S. SayadChief Medical Officer
- TETerry EvansChief Commercial Officer
- CCChristiana CioffiChief Strategy Officer
- CAChris A. RallisIndependent Director
- MMMarco Maria BrugheraIndependent Director
- JAJodi Ann CookIndependent Director
